Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
14 Oct 2008 Study Finds Improved Absorption of Oral Salmon Calcitonin Versus Nasal Administration
20 Aug 2008 DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine
14 Aug 2008 Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb
06 Aug 2008 Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
05 Aug 2008 Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis...
03 Aug 2008 MDRNA, Inc. Demonstrates In Vivo Efficacy with Proprietary DiLA2 Delivery Platform
28 Jul 2008 Eligen(R) B12 oral formulation demonstrates 240% improvement in bioavailability versus standard oral Vitamin B12 tablet and different absorption characteristics
16 Jul 2008 BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer, following advice from the Drug Safety Monitoring Board and the Steering Committee
10 Jul 2008 Altus Pharmaceuticals Secures Long-Term Growth Hormone Supply For ALTU-238 Clinical Development and Commercialization
10 Jul 2008 Modigene Platform Validated in Independent Phase III Trial of CTP Technology
08 Jul 2008 Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
30 Jun 2008 Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
25 Jun 2008 Promising Results for Oral CP-4126
25 Jun 2008 SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA
12 Jun 2008 Lilly and TransPharma Medical Announce Licensing and Development Agreement
01 May 2008 Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
30 Apr 2008 Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
30 Apr 2008 Phosphagenics Reports Positive Pre-clinical Results for
29 Apr 2008 Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
16 Apr 2008 Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
09 Apr 2008 Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
09 Apr 2008 Pfizer Statement on Exubera Labeling Update in the United States
02 Apr 2008 Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
30 Mar 2008 QLT initiates Phase II study of punctal plug drug delivery system for Glaucoma & Ocular Hypertension
30 Mar 2008 QLT initiates Phase II study of punctal plug drug delivery system for Glaucoma & Ocular Hypertension
19 Mar 2008 Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
19 Mar 2008 Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
13 Mar 2008 AstraZeneca signs drug delivery collaboration
12 Mar 2008 Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin
11 Mar 2008 Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy
11 Mar 2008 OctoPlus announces publication of Phase I Locteron results in the Journal of Interferon and Cytokine Research
11 Mar 2008 Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
07 Mar 2008 Alkermes Provides Update on Inhaled Insulin Program
07 Mar 2008 Lilly Announces Termination of AIR Insulin Program
03 Mar 2008 Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
25 Feb 2008 Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
19 Feb 2008 Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid
12 Feb 2008 Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes
12 Feb 2008 Hana Biosciences Announces Top-Line Phase 1 Clinical Trial Data Demonstrating Alocrest to be Well-Tolerated With Promising Anti-Tumor Activity
11 Feb 2008 Bentley Pharmaceuticals Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results
11 Feb 2008 Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin
06 Feb 2008 OctoPlus commences United States Phase IIa study with Locteron for the treatment of hepatitis C
05 Feb 2008 Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
22 Jan 2008 Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
22 Jan 2008 Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology
21 Jan 2008 iCo Therapeutics Provides iCo-009 (Oral Amphotericin B) Update
17 Jan 2008 YM BioSciences Provides Update on AeroLEF(TM) Clinical Development Program
09 Jan 2008 Amarin Announces Successful Outcome of Nasal Lorazepam Study
02 Jan 2008 NEOPHARM Announces IND Filing for Novel Liposomal Delivery System of Docetaxel
27 Dec 2007 Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 1 - 50 of 412

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics